Assertio Holdings, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Mark L. Reisenauer, with a market cap of $125.0M.
Common questions about Assertio Holdings, Inc.
Assertio Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $10.9M.
Assertio Holdings, Inc. has approximately 30 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.